By Dr Alys Havard

Conference Papers

Tran D; Cohen JM; Donald S; Robijn A; Cesta C; Kuru K; Parkin L; Pearson S; Johan R; Zoega H; Zwar N; Havard A, 2024, 'Does use of smoking cessation pharmacotherapies during pregnancy increase the risk of congenital malformations in infants: Findings from a multi-national study', Edinburgh, Scotland, United Kingdom, presented at Society for Research on Nicotine and Tobacco Annual Meeting, Edinburgh, Scotland, United Kingdom, 20 March 2024 - 23 March 2024

Robijn A; Tran D; Cohen JM; Donald S; Cesta CE; Furu K; Pearson S; Reutfors J; Zoega H; Zwar N; Havard A, 2023, 'Prevalence of smoking cessation pharmacotherapy use during pregnancy: a multi-national population-based study', Sydney, presented at Centre of Research Excellence in Medicines Intelligence Symposium 2023, Sydney, 02 November 2023 - 03 November 2023

Tran D; Cohen JM; Donald S; Robijn A; Cesta CE; Kuru K; Parkin L; Pearson S; Reutfors J; Zoega H; Zwar N; Havard A, 2023, 'The risk of congenital malformations in infants exposed in the first trimester to smoking cessation pharmacotherapies: A multi-national cohort study', Sydney, presented at Centre of Research Excellence in Medicines Intelligence Symposium 2023, Sydney, 02 November 2023 - 03 November 2023

Robijn A; Tran D; Cesta CE; Cohen JM; Donald S; Furu K; Parkin L; Pearson S; Reutfors J; Zoega H; Zwar N; Havard A, 2023, 'Utilisation of smoking cessation pharmacotherapies during pregnancy: a multi-national population-based study', Adelaide, South Australia, presented at APSAD Australasian Professional Society on Alcohol and other Drugs 2023, Adelaide, South Australia, 27 October 2023 - 30 October 2023

Grice B; Robijn A; Chambers M; Havard A, 2023, 'E-cigarette Use among Australian Women of Reproductive Age', in NDARC, presented at National Drug and Alcohol Research Centre Annual Symposium, 26 October 2023

Tran D; Cesta CE; Cohen JM; Donald S; Furu K; Kelty E; Parkin L; Pearson S; Reutfors J; Robijn AL; Zoega H; Zwar N; Havard A, 2023, 'The safety of quit smoking medications during pregnancy: the risk of congenital malformations in infants', UNSW Sydney, presented at National Drug and Alcohol Research Centre Symposium 2023, UNSW Sydney, 26 October 2023

Tran D; Cesta CE; Cohen JM; Donald S; Kari F; Kelty E; Parkin L; Pearson S; Johan R; Robijn A; Zoega H; Nicholas Z; Havard A, 2023, 'First trimester exposure to smoking cessation pharmacotherapies and the risk of major congenital malformations: A multi-national cohort study', Halifax, Nova Scotia, Canada, presented at 39th International Conference on Pharmacoepidemiology and Therapeutic Risk Management, Halifax, Nova Scotia, Canada, 23 August 2023

Havard A; Choi SKY; Pearson S-A; Chow CK; Tran DT; Filion KB, 2021, 'THE COMPARATIVE CARDIOVASCULAR SAFETY OF SMOKING CESSATION PHARMACOTHERAPIES', in DRUG AND ALCOHOL REVIEW, WILEY, pp. S78 - S79, https://www.webofscience.com/api/gateway?GWVersion=2&SrcApp=PARTNER_APP&SrcAuth=LinksAMR&KeyUT=WOS:000715073200195&DestLinkType=FullRecord&DestApp=ALL_WOS&UsrCustomerID=891bb5ab6ba270e68a29b250adbe88d1

Havard A; Chidwick K; Daniels B; Thistlethwaite J; Myton R; Blogg S; Wall M; Quick L; Pollack A; Manski-Nankervis J-A, 2021, 'Validity of algorithms for identifying five chronic conditions in MedicineInsight, Australian national primary care data', in INTERNATIONAL JOURNAL OF EPIDEMIOLOGY, OXFORD UNIV PRESS, http://dx.doi.org/10.1093/ije/dyab168.270

Cohen J; Alvestad S; Suarez E; Schaffer A; Selmer R; Havard A; Bateman B; Zoega H; Kieler H; Odsbu I; Huybrechts K; Kjerpeseth L; Straub L; Leinonen M; Bjork M-H; Norgaard M; Gissler M; Ulrichsen S; Hernandez-Diaz S; Tomson T; Furu K, 2021, 'The Comparative Safety of Antiseizure Medication Polytherapy vs Valproate in Pregnancy and Risk of Major Congenital Malformations', in Pharmacoepidemiology and Drug Safety, John Wiley and Sons, Virtual, pp. 73 - 74, presented at International Conference on Pharmacoepidemiology and Therapeutic Risk Management, Virtual, 23 August 2021 - 25 August 2021

Varney B; Gilles MB; Havard A; Zoega H; Pearson S-A; Litchfield M, 2021, 'Prescription opioid use in Australian women of reproductive age from 2013 to 2020', in PHARMACOEPIDEMIOLOGY AND DRUG SAFETY, WILEY, pp. 308 - 309, https://www.webofscience.com/api/gateway?GWVersion=2&SrcApp=PARTNER_APP&SrcAuth=LinksAMR&KeyUT=WOS:000687807300627&DestLinkType=FullRecord&DestApp=ALL_WOS&UsrCustomerID=891bb5ab6ba270e68a29b250adbe88d1

Schaffer A; Zoega H; Tran DT; Buckley N; Pearson S; Havard A, 2019, 'Trajectories of antipsychotic use before and during pregnancy and related maternal and birth characteristics', in Pharmacoepidemiology and Drug Safety, Wiley, Philadelphia, USA, pp. 216 - 216, presented at International Conference on Pharmacoepidemiology, Philadelphia, USA, 24 August 2019 - 28 August 2019, http://dx.doi.org/10.1002/pds.4864

Havard A; Choi SKY; Chow CK; Tran DT; Filion KB, 2019, 'Risk of Major Cardiovascular Events Associated with Varenicline and Nicotine Replacement Therapy: An Australian Population-Based Study', in PHARMACOEPIDEMIOLOGY AND DRUG SAFETY, WILEY, pp. 20 - 20, https://www.webofscience.com/api/gateway?GWVersion=2&SrcApp=PARTNER_APP&SrcAuth=LinksAMR&KeyUT=WOS:000481785600033&DestLinkType=FullRecord&DestApp=ALL_WOS&UsrCustomerID=891bb5ab6ba270e68a29b250adbe88d1

Bilal A; Tran D; Zoega H; Sean K; Jorm L; Havard A, 2018, 'Safety of renin-angiotensin system blockers in early pregnancy', Sydney, presented at 54th Australian and New Zealand Society of Nephrology Annual Scientific Meeting, Sydney, 08 September 2018

Choi S; Tran DT; Preen DB; Deborah R; Kemp-Casey A; Einarsdottir K; Jorm LR; Havard A, 2018, 'Varenicline is more effective than nicotine replacement therapy during pregnancy: Findings from the smoking mums (maternal use of medications and safety) study', Prague, Czech Republic, presented at The 34th International Society for Pharmacoepidemiology Annual Conference, Prague, Czech Republic, 22 August 2018 - 26 August 2018

Tran DT; Preen DB; Einarsdottir K; Kemp-Casey A; Randall D; Choi S; Jorm LR; Havard A, 2018, 'First trimester exposure to varenicline was not associated with increased risk of major birth defects: Findings from the smoking MUMS (Maternal Use of Medications and Safety) study', in PHARMACOEPIDEMIOLOGY AND DRUG SAFETY, WILEY, pp. 352 - 352, https://www.webofscience.com/api/gateway?GWVersion=2&SrcApp=PARTNER_APP&SrcAuth=LinksAMR&KeyUT=WOS:000441893803093&DestLinkType=FullRecord&DestApp=ALL_WOS&UsrCustomerID=891bb5ab6ba270e68a29b250adbe88d1

Lee ML; Havard A; Tran DT; Kennedy D; Welsh A, 2018, 'Healthcare providers' concerns regarding smoking cessation pharmacotherapies in pregnancy: calls to a teratology information service', in TOBACCO INDUCED DISEASES, EUROPEAN PUBLISHING, pp. 322 - 322, http://dx.doi.org/10.18332/tid/84029

Bilal A; Havard A; Tran D; Sean K; Jorm L, 2017, 'Risk of adverse perinatal outcomes associated with early pregnancy use of renin-angiotensin system blockers for the management of chronic hypertension', Brisbane, presented at ISPE's 10th Asian Conference on Pharmacoepidemiology, Brisbane, 29 October 2017

Tran DT; Havard A; Preen DB; Einarsdottir K; Kemp-Casey A; Randall D; Jorm LR, 2017, 'Birth Outcomes Associated with the Use of Smoking Cessation Pharmacotherapies in Pregnancy: Findings from the Smoking MUMS (Maternal Use of Medications and Safety) Study', in PHARMACOEPIDEMIOLOGY AND DRUG SAFETY, WILEY, pp. 435 - 436, https://www.webofscience.com/api/gateway?GWVersion=2&SrcApp=PARTNER_APP&SrcAuth=LinksAMR&KeyUT=WOS:000437104300321&DestLinkType=FullRecord&DestApp=ALL_WOS&UsrCustomerID=891bb5ab6ba270e68a29b250adbe88d1

Raichand S; Pearson SA; Buckley NA; Havard A, 2017, 'Estimating the Average Daily Dose of Teratogenic Medicines Dispensed to Women of Child-Bearing Age', in PHARMACOEPIDEMIOLOGY AND DRUG SAFETY, WILEY, pp. 417 - 417, https://www.webofscience.com/api/gateway?GWVersion=2&SrcApp=PARTNER_APP&SrcAuth=LinksAMR&KeyUT=WOS:000437104300290&DestLinkType=FullRecord&DestApp=ALL_WOS&UsrCustomerID=891bb5ab6ba270e68a29b250adbe88d1

Havard A; Tran DT; Preen DB; Einarsdottir K; Jorm LR, 2017, 'Is the Use of Smoking Cessation Pharmacotherapies During Pregnancy Consistent with Clinical Guidelines? Findings from the Smoking MUMS (Maternal Use of Medications and Safety) Study', in PHARMACOEPIDEMIOLOGY AND DRUG SAFETY, WILEY, pp. 506 - 507, https://www.webofscience.com/api/gateway?GWVersion=2&SrcApp=PARTNER_APP&SrcAuth=LinksAMR&KeyUT=WOS:000437104300436&DestLinkType=FullRecord&DestApp=ALL_WOS&UsrCustomerID=891bb5ab6ba270e68a29b250adbe88d1

Ahmed B; Tran D; Jorm L; Havard A, 2017, 'Prevalence of renin-angiotensin system (RAS) blockers exposure during pregnancy and the clinical indications: A Population-Based Cohort Study in NSW (2005-2012).', Canberra, presented at Perinatal Society of Australia and New Zealand, Canberra, 02 May 2017

Tran DT; Havard A; Jorm L, 2016, 'Algorithms for assessing person-based consistency among linked records for the investigation of maternal use of medications and safety', in International Journal for Population Data Science, Swansea University, Swansea, pp. 212, presented at International Population Data Linkage Network Conference, Swansea, 24 August 2016 - 26 August 2016, http://dx.doi.org/10.23889/ijpds.v1i1.212

Tran DT; Jorm L; Havard A; Harris MF; Comino E, 2015, 'Variation in the use of primary care services for diabetes management according to country of birth and geography among older Australians', Melbourne, Australia, presented at 9th Health Services and Policy Research Conference, Melbourne, Australia, 07 December 2015 - 09 December 2015

Gibson A; Randall D; Tran D; Byrne M; Lawler A; Havard A; Robinson M; Jorm L, 'Emergency department attendance after telephone triage', in International journal of population data science

Havard A; Lujic S; Tran D; Jorm L, 'Refining an antidepressant-based indicator to improve the ascertainment of depression from Australian administrative data', in International journal of population data science

Back to profile page